MoneyWorks4Me

NGL Fine Chem informs about board meeting

20 Jan 2016 Evaluate

NGL Fine Chem has informed that a meeting of the Board of Directors of the Company will be held on February 09, 2016, to approve Un-Audited Financial Results along with Limited review report submitted by Statutory Auditor for the quarter ended on December 31, 2015, and adoption of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations) including authorizing any Director of the Company to enter into amended Listing Agreement and submission of the same to BSE and any other applicable authorities, if required.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..